Efficacy and Safety of tadalafil 20 mg on demand vs. tadalafil 5 mg once-a-day in the treatment of post-radiotherapy erectile dysfunction in prostate cancer men: A randomized phase II trial

Umberto Ricardi, Paolo Gontero, Patrizia Ciammella, Serena Badellino, Franco Valentino, Fernando Munoz, Alessia Guarneri, Nadia Rondi, Francesco Moretto, Andrea Riccardo Filippi, Riccardo Ragona, Alessandro Tizzani

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Efficacy and Safety of tadalafil 20 mg on demand vs. tadalafil 5 mg once-a-day in the treatment of post-radiotherapy erectile dysfunction in prostate cancer men: A randomized phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences